BrainChip Holdings (ASX: BRN) – Q10 2026 Quarterly Activities Report
BrainChip Holdings Limited provided its quarterly activities report for the period ending 31 March 2026, with notable progress on production...
BrainChip Holdings Limited provided its quarterly activities report for the period ending 31 March 2026, with notable progress on production...
Clinuvel Pharmaceuticals has received final regulatory guidance from the European Medicines Agency on the design of its Phase III vitiligo trial,...
EVT Limited expects to deliver normalised EBITDA growth for the full year ending 30 June 2026, maintaining growth guidance despite a range of...
St Barbara Limited has approved a Final Investment Decision to restart processing operations at its Touquoy mine in Nova Scotia, marking a...
Fortescue delivered record nine-month iron ore shipments of 148.7 million tonnes, representing a four percent increase compared to the same period...